Oragenics Inc
NYSE: OGEN
- Raised $850,000 (2023)
- 3 clinical trials, 1 active
- Research grants: $713,308
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
SQZ Biotechnologies Co
- Raised $66 million (2020)
- 3 clinical trials
- Research grants: $10 million
- Founded 2013
Oncternal Therapeutics, Inc.
- Raised $6.5 million (2020)
- 5 clinical trials
- Research grants: $8.4 million
- Founded 2013
Ultragenyx Pharmaceutical Inc.
Nasdaq: RARE
- Raised $75 million (2012)
- 62 clinical trials, 18 active
- 3 FDA-registered drug sites
- Founded 2011
Visby Medical, Inc.
- Raised $109 million (2022)
- 3 clinical trials
- FDA-cleared or approved devices
- Research grants: $3.8 million
Elucid Bioimaging Inc.
- Raised $36 million (2025)
- 5 clinical trials
- FDA-cleared or approved devices
- Research grants: $8.3 million
Tissuetech, Inc.
- Raised $55 million (2019)
- 15 clinical trials
- FDA-cleared or approved devices
- Research grants: $8.4 million
Clear Guide Medical, Inc.
- Raised $1.2 million (2016)
- 9 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $15 million
Viatris Inc
Nasdaq: VTRS
- 221 clinical trials, 3 active
- FDA-cleared or approved devices
- 7 FDA-registered drug sites
Ocular Therapeutix, Inc
Nasdaq: OCUL
- Raised $38 million (2019)
- 33 clinical trials, 4 active
- 1 FDA-registered drug site
- Founded 2006
ELI LILLY & Co
NYSE: LLY
- 2325 clinical trials, 248 active
- FDA-cleared or approved devices
- 6 FDA-registered drug sites
Penumbra Inc
NYSE: PEN
- Raised $121,230 (2012)
- 33 clinical trials, 5 active
- FDA-cleared or approved devices
CoapTech, Inc.
- Raised $7.1 million (2024)
- 4 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $7.6 million
Dexcom Inc
Nasdaq: DXCM
- Raised $7.2 million (2016)
- 38 clinical trials, 6 active
- FDA-cleared or approved devices
Bright Uro, Inc.
- Raised $15 million (2025)
- 5 clinical trials, 4 active
- FDA-cleared or approved devices
- Research grants: $4.1 million
Ceribell, Inc.
Nasdaq: CBLL
- Raised $103 million (2022)
- 4 clinical trials, 3 active
- FDA-cleared or approved devices
Xeris Pharmaceuticals Inc
- Raised $30 million (2017)
- 15 clinical trials
- Research grants: $14 million
Nuvasive Inc
- Raised $40 million (2011)
- 38 clinical trials, 9 active
- FDA-cleared or approved devices
iRhythm Holdings, Inc.
Nasdaq: IRTC
- Raised $27 million (2015)
- 4 clinical trials
- FDA-cleared or approved devices
- Founded 2006
Actinium Pharmaceuticals, Inc.
NYSE: ATNM
- Raised $6.6 million (2014)
- 6 clinical trials, 2 active
- Research grants: $4.2 million
Showing 120 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences